Cooperative Binding of Upstream Stimulatory Factor and Hepatic Nuclear Factor 4 Drives the Transcription of the Human Apolipoprotein A-II Gene
The activity of the human apoA-II promoter is controlled by a synergistic interaction of the distal enhancer and the proximal promoter. An important role in apoA-II promoter activity is exerted by a transcription factor, designated CIIIB1, which binds to the proximal element AB and the distal elemen...
Saved in:
Published in | The Journal of biological chemistry Vol. 274; no. 3; pp. 1216 - 1225 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Biochemistry and Molecular Biology
15.01.1999
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The activity of the human apoA-II promoter is controlled by a synergistic interaction of the distal enhancer and the proximal
promoter. An important role in apoA-II promoter activity is exerted by a transcription factor, designated CIIIB1, which binds
to the proximal element AB and the distal elements of the enhancer, K and L. In the present communication we establish that
CIIIB1 corresponds to the previously described factor, upstream stimulatory factor (USF) using the following criteria. ( a ) Purification of CIIIB1 by affinity chromatography provided a heat-stable protein with an apparent molecular mass of 45 kDa
that cross-reacted with anti-USF1 and -USF2a antibodies; ( b ) CIIIB1 bound to the elements AB, K, and L was supershifted by these antibodies; ( c ) the heterodimer USF1/2a is the predominant form that corresponds to CIIIB1. Cotransfection experiments in HepG2 cells established
the functional significance of USF in apoA-II transcription. It was found that the minimal promoter AB was transactivated
by USF2a. In addition, all three E-box motifs present in elements AB, K and L are necessary for maximum transactivation by
USF2a. A dominant negative form of USF2a inhibits the activity of apoA-II promoter. The USF1/2a heterodimer, which is naturally
expressed in the liver, is as efficient as the USF2a homodimer in the transactivation of apoA-II promoter/enhancer constructs.
Cotransfection experiments in COS-1 cells showed that hepatic nuclear factor 4 (HNF-4) synergized with USF2a in the transactivation
of the apoA-II promoter. In addition, we showed that HNF-4 and USF2a bind to the enhancer cooperatively. This may account
for the transcriptional synergism observed between USF and HNF-4 in the transactivation of the apoA-II promoter. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.274.3.1216 |